Q: I'd like to know what your current view is on MCR. In response to a question I posed on Dec 9/14 the answer was "Macro had a very tough year; even before the recent energy sector meltdown, it experienced cost overruns on a fixed cost project, and this destroyed its profit margins. Now, sector retrenchment means there will likely be fewer opportunities for growth over the next two years. But.....it is still profitable, and very cheap. It has some debt, which may be more of a concern if there is not a recovery. After its big drop, we would consider it a hold, but would not buy any more. Note however that its small size now adds some more risks, especially in the short term while the sector tries to stabilize. We think it survives this cycle, but you will likely need to commit to it for another two years."
Yet, in a response to another persons question on Jan 16/15 you respond: "...Both stocks are very, very cheap, reflecting the debt and the sector. As far as survivability goes, much depends on how long the sector situation lasts. MCR, likely, has a better ability to reduce costs, as CET owns its equipment and when business slows it earns nothing on unused equipment. MCR insiders have much more skin in the game than CET insiders.
With the risk of the dividend cut hurting CET, we would reluctantly side with MCR today. But neither looks particularly interesting to us anymore. "
I realize that not the same person answers questions, and there was a period of time between those questions, and now...
What is your current view? Is it worth holding, or time to sell while I can still get something out of it.
Q: Hi Peter and Team, regarding AHF, would you consider the stock a soft hold, a strong hold or simply a sell into this current strength? Almost at break even at .90 cents. Thanks!
Sylogist declared quite good results and they did an equity offering for 11 cad. They did a few acquistions too if I am not mistaken. Conventional wisdom states that a company grows by acquistions case in point csu,valient, Amaya so why is sylogist not following. They also increased their dividend what else do they have to do to increase their share value your
comments will be appreciated.
Q: convalo has 76 million warrants that have to be exercised at 20 cents i think in the next 2 weeks. my question is convalo hit an intraday high of .385 cents, but i would think it would sell off considerably as shareholders sell the stock to exercise the warrants. am i right or wrong. dave
Q: Hi Peter and Co.
I looked at VNP numbers from last night's earnings release and I'm trying to find a positive somewhere in them but I'm struggling mightily. They look pretty awful. I suppose the only positive is that the stock isn't down more today.
Your thoughts?
Thanks,
Michael
Q: You previously told a subscriber you expected these guys to raise money soon and they have as of today but does this generally help or hinder stock prices uniformly as it is down 13 cents today. Do you think this makes it any less speculative.
Q: Good morning.
You made a comment last March that if Electrovaya was to become profitable we would have time get prepared. Recently they have been very busy announcing plans and deals and I’m wondering if it’s time to have a closer look.
They have announced a plan to acquire and update a large manufacturing facility (Nov. 17), and they have announced deals with Walmart (Nov 10), a deal with Toronto Hydro and London Hydro (Nov 12) as well as a number of other deals.
What is your opinion on these recent developments?
Read Answer
Asked by Dr Lorraine on February 24, 2015
Q: Do you recommend buying the above companies. What are the good qualities and risks of holding each and what should be the size in a portfolio? Thanks
Q: Can you please comment on Sylogist results released this evening.Do you see an improving trend ? Any thoughts on : "During the past year we deferred opportunities in our Canadian public sector unit and payment solutions operations to invest in our foundational technology, moving Sylogist products well ahead of market competitors. We are encouraged by the early financial success of these investments as noted in our MD&A"
Q: Would you agree we are still in a large-cap market, especially in the US? Is it a good time to move into small-cap and mid-cap positions, such as XUU (US exposure) and the Mawer Global small cap fund (global exp.) and any suggestions for Cdn small cap exposure?
Q: I have a small amount of extra USD cash in my TFSA and would like to put it into an ultra speculative high growth stock. Do you have anything intersting on your radar out of the US?
Q: Hello 5i: Further to Harvey's question on ARF. If insiders were given the financials, would this indicate a leak? What are your thoughts on this company as it has fallen a long way from its glory days in 2010 and 2011 and still hanging in there? I would appreciate your comments on my two questions.
Thank you
Q: Since your last update on NeuLion the shares improved a little, then fell back once again.
I know it is not a long period of time since the last update but I am wondering if your views have changed. In particular I am think about selling Neulion and buying Espial. Your thoughts on this swith would be appreciated
Q: What do you think of cantor fitzgerald's take on Tecsys:
http://www.cantechletter.com/2015/02/tecsys-double-triple-says-cantor-fitzgerald/
Too optimistic? Should I switch my Sylogist for TCS for a three to five year hold? Thanks again.
Q: Hi Peter and Co.,
I'm a shareholder of VNP and they are releasing earnings tomorrow. Would you happen to know what the consensus expectations are for tomorrow's release?
Thanks,
Michael